| AstraZeneca submits Brilinta NDA to FDA | 11/19/2009 - 09:06 |
| Genentech, Biogen Idec get FDA request on application for Rituxan's use in leukemia | 11/19/2009 - 07:52 |
| Obesity and ED: Two Big Markets, One Tiny Company | 11/19/2009 - 07:50 |
| Pfizer to Begin Selling Generics in Japan | 11/19/2009 - 07:49 |
| AstraZeneca May Face 6,000 Seroquel Trials as Judge to Urge Cases' Return | 11/19/2009 - 06:41 |
| Drugmaker Reinvents Itself And Expands Footprint Internationally | 11/19/2009 - 06:40 |
| Four Healthcare Stocks On Fire | 11/19/2009 - 06:38 |
| FDA panel backs Pfizer's enhanced vaccine for kids | 11/19/2009 - 06:37 |
| On the Radar: November's biotech stocks to watch | 11/18/2009 - 12:17 |
| Crestor shines, Vitamin D intrigues at AHA confab | 11/18/2009 - 12:14 |
| Researchers will test Pfizer pipeline to find treatments for some tropical illnesses | 11/18/2009 - 12:13 |
| GSK Takes Dow Jones to Task - on Its Blog | 11/18/2009 - 10:18 |
| Good News for Alkermes' Pipeline | 11/18/2009 - 10:15 |
| Biotech Stocks Hot Right Now, Ho-Hum in the Long Run | 11/18/2009 - 10:13 |
| NicOx to Sell New Shares as FDA Agrees to Review Arthritis Drug | 11/18/2009 - 09:33 |
| Another Genzyme Drug Goes Kaboom | 11/18/2009 - 09:09 |
| Drugmakers' Differences: Analyst's Toolkit | 11/18/2009 - 09:06 |
| Vivus Erection Drug Worked Within 30 Minutes in Study | 11/18/2009 - 09:05 |
| Mead Johnson: This Poison Pill Aids Investors | 11/18/2009 - 09:03 |
| Answering The Vytorin Question | 11/18/2009 - 09:02 |
| Crestor Cuts Cardiovascular Problems In Women | 11/17/2009 - 17:27 |
| Titan Pharmaceuticals: Finally Reaching Its Potential | 11/17/2009 - 17:22 |
| BioCryst hopes to raise $57M with stock offering | 11/17/2009 - 16:07 |
| Oxigene's developing cancer treatment meets safety goals in midstage study | 11/17/2009 - 14:17 |
| Vaccines on horizon for AIDS, Alzheimer's, herpes | 11/17/2009 - 14:16 |
| Brilinta bests Plavix in trial | 11/17/2009 - 14:15 |
| A Big Upgrade for Sanofi-Aventis | 11/17/2009 - 11:35 |
| Merck dodged Zetia bullet, analysts say | 11/17/2009 - 11:34 |
| Drug-price outcry threatens to derail reform | 11/17/2009 - 11:33 |
| Human Genome's ABthrax Faces FDA Delay | 11/17/2009 - 11:21 |
